These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 37827694)

  • 1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
    Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae SC; Boletis J; Bruce IN; Cervera R; Doria A; Dörner T; Furie RA; Gladman DD; Houssiau FA; Inês LS; Jayne D; Kouloumas M; Kovács L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2024 Jan; 83(1):15-29. PubMed ID: 37827694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
    Fanouriakis A; Kostopoulou M; Alunno A; Aringer M; Bajema I; Boletis JN; Cervera R; Doria A; Gordon C; Govoni M; Houssiau F; Jayne D; Kouloumas M; Kuhn A; Larsen JL; Lerstrøm K; Moroni G; Mosca M; Schneider M; Smolen JS; Svenungsson E; Tesar V; Tincani A; Troldborg A; van Vollenhoven R; Wenzel J; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2019 Jun; 78(6):736-745. PubMed ID: 30926722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EULAR recommendations 2023 on the treatment of systemic lupus erythematosus -Implications for treatment in Germany].
    Mucke J; Aringer M
    Z Rheumatol; 2024 Aug; 83(6):431-438. PubMed ID: 39037547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
    Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update οn the diagnosis and management of systemic lupus erythematosus.
    Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
    Trindade VC; Carneiro-Sampaio M; Bonfa E; Silva CA
    Paediatr Drugs; 2021 Jul; 23(4):331-347. PubMed ID: 34244988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment.
    Reis-Neto ETD; Seguro LPC; Sato EI; Borba EF; Klumb EM; Costallat LTL; Medeiros MMDC; Bonfá E; Araújo NC; Appenzeller S; Montandon ACOES; Yuki EFN; Teixeira RCA; Telles RW; Egypto DCSD; Ribeiro FM; Gasparin AA; Junior ASA; Neiva CLS; Calderaro DC; Monticielo OA
    Adv Rheumatol; 2024 Jun; 64(1):48. PubMed ID: 38890752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Algorithms in Systemic Lupus Erythematosus.
    Muangchan C; van Vollenhoven RF; Bernatsky SR; Smith CD; Hudson M; Inanç M; Rothfield NF; Nash PT; Furie RA; Senécal JL; Chandran V; Burgos-Vargas R; Ramsey-Goldman R; Pope JE
    Arthritis Care Res (Hoboken); 2015 Sep; 67(9):1237-1245. PubMed ID: 25777803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for cutaneous disease in systemic lupus erythematosus.
    Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Lupus Erythematosus: A Review.
    Siegel CH; Sammaritano LR
    JAMA; 2024 May; 331(17):1480-1491. PubMed ID: 38587826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA; Huq M; Godfrey T; Oon S; Calderone A; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Jan Wu YJ; Golder V; Lateef A; Navarra SV; Zamora L; Hamijoyo L; Sockalingam S; An Y; Li Z; Katsumata Y; Harigai M; Chan M; Goldblatt F; O'Neill S; Lau CS; Cho J; Hoi A; Karyekar CS; Morand EF; Nikpour M
    Adv Rheumatol; 2024 May; 64(1):38. PubMed ID: 38720354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of therapeutic strategies in severe systemic lupus erythematosus-associated immune thrombocytopenia: a retrospective cohort study of response and relapse.
    Cimé-Aké E; Barrera-Vargas A; Demichelis-Gómez R; Ramírez-Alemón M; Rull-Gabayet M
    Clin Rheumatol; 2024 Aug; 43(8):2521-2532. PubMed ID: 38916764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Treatment Strategies for Lupus Nephritis.
    Karasawa K; Uchida K; Takabe T; Moriyama T; Nitta K
    Contrib Nephrol; 2018; 195():42-50. PubMed ID: 29734149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
    Ramos-Casals M; Brito-Zerón P; Bombardieri S; Bootsma H; De Vita S; Dörner T; Fisher BA; Gottenberg JE; Hernandez-Molina G; Kocher A; Kostov B; Kruize AA; Mandl T; Ng WF; Retamozo S; Seror R; Shoenfeld Y; Sisó-Almirall A; Tzioufas AG; Vitali C; Bowman S; Mariette X;
    Ann Rheum Dis; 2020 Jan; 79(1):3-18. PubMed ID: 31672775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
    Constantin A; Năstase D; Tulbă D; Bălănescu P; Băicuș C
    Lupus; 2020 Oct; 29(12):1509-1519. PubMed ID: 32757735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations.
    Kostopoulou M; Mukhtyar CB; Bertsias G; Boumpas DT; Fanouriakis A
    Ann Rheum Dis; 2024 Oct; 83(11):1489-1501. PubMed ID: 38777375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus: review of synthetic drugs.
    Tsang-A-Sjoe MW; Bultink IE
    Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.